Business description
Vita 34 was founded in 1997 as the first private umbilical cord blood bank in Europe and, as a complete provider, offers collection logistics, preparation and storage of umbilical cord blood and cord tissue. The basis for its successful work is an outstanding position in the technological segment of cryo-preservation. Here, cells and tissue are preserved alive at some -190ºC for long periods of time, and can be used if needed in the context of medical treatment.
Management board & Supervisory board
| CEO |
| Jakub Baran |
| Management board |
| Dirk Plaga, Tomasz Baran |
| Supervisory board |
| Florian Schuhbauer, Steffen Richtscheid, Andreas Füchsel, Frank Köhler |
Company data
| Name: |
VITA 34 AG |
| Address: |
Deutscher Platz 5,D-04103 Leipzig |
| Phone: |
+49-341-48792-0 |
| Fax: |
+49-341-48792-20 |
| E-mail: |
info@vita34.com
|
| Internet: |
www.vita34.de |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
21.93% |
| IPO date: |
2007-03-27 |
Investor relations
| Name: |
Dr. Wolfgang Knirsch |
| IR phone: |
+49-341-48792-40 |
| IR Fax: |
+49-341-48792-39 |
| IR e-mail: |
ir@vita34group.de
|
